Methemalbumin and Pancreatitis: A Warning

  1. P. D. SCHOW, M.D.; and
  2. E. ENGLERT, JR., M.D.
  1. Department of Medicine
    University of Utah College of Medicine,
    and Veterans Administration Hospital
    Salt Lake City, Utah 84132

    Excerpt

    To the editor: Most acute pancreatitis is of the edematous type and has a low mortality of about 5%. In contrast, the hemorrhagic type is uncommon, accounting for about 15% of acute pancreatitis, but with a high mortality of between 50% and 90%. Such statistics often lull the physician into the expectancy of benignity and confound results of therapeutic clinical trials. They should instead make it a high priority to distinguish the two types in a given patient. Neither clinical severity nor any laboratory test can do this infallibly. Shock, hypocalcemia, prolonged hyperenzymemia, skin changes, and thromboembolic phenomena may occur

    This 100-word excerpt has been provided in the absence of an abstract.

    | Table of Contents
    Most Read Most Read
    Most Commented Most Commented On
    Annals in the News Annals in the News
    Clinical Trials Clinical Trials
    Comparative Effectiveness Comparative Effectiveness
    Hospital Medicine Hospital Medicine
    • Advertisement
    • Advertisement